Feinstein Institutes Secures $6.1M NIH Grant for Red Cell Disorder Research

MANHASSET, N.Y.--(BUSINESS WIRE)--Red cell disorders, such as Diamond-Blackfan anemia (DBA) and sickle cell disease (SCD), affect more than 1 billion people worldwide and are a significant cause of chronic illness and mortality. To further our understanding and potential treatments of these disorders, The Feinstein Institutes for Medical Research has been awarded a $6.1 million grant from the National Institutes of Health (NIH). Led by Lionel Blanc, PhD, professor in the Institute of Molecular